Literature DB >> 23530127

Amplitude modulation of androgen signaling by c-MYC.

Min Ni1, Yiwen Chen, Teng Fei, Dan Li, Elgene Lim, X Shirley Liu, Myles Brown.   

Abstract

Androgen-stimulated growth of the molecular apocrine breast cancer subtype is mediated by an androgen receptor (AR)-regulated transcriptional program. However, the molecular details of this AR-centered regulatory network and the roles of other transcription factors that cooperate with AR in the network remain elusive. Here we report a positive feed-forward loop that enhances breast cancer growth involving AR, AR coregulators, and downstream target genes. In the absence of an androgen signal, TCF7L2 interacts with FOXA1 at AR-binding sites and represses the basal expression of AR target genes, including MYC. Direct AR regulation of MYC cooperates with AR-mediated activation of HER2/HER3 signaling. HER2/HER3 signaling increases the transcriptional activity of MYC through phosphorylation of MAD1, leading to increased levels of MYC/MAX heterodimers. MYC in turn reinforces the transcriptional activation of androgen-responsive genes. These results reveal a novel regulatory network in molecular apocrine breast cancers regulated by androgen and AR in which MYC plays a central role as both a key target and a cooperating transcription factor to drive oncogenic growth.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23530127      PMCID: PMC3639415          DOI: 10.1101/gad.209569.112

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  36 in total

1.  FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription.

Authors:  Mathieu Lupien; Jérôme Eeckhoute; Clifford A Meyer; Qianben Wang; Yong Zhang; Wei Li; Jason S Carroll; X Shirley Liu; Myles Brown
Journal:  Cell       Date:  2008-03-21       Impact factor: 41.582

2.  CEAS: cis-regulatory element annotation system.

Authors:  Hyunjin Shin; Tao Liu; Arjun K Manrai; X Shirley Liu
Journal:  Bioinformatics       Date:  2009-08-18       Impact factor: 6.937

3.  Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancers.

Authors:  Aurélien A Sérandour; Stéphane Avner; Frédéric Percevault; Florence Demay; Maud Bizot; Céline Lucchetti-Miganeh; Frédérique Barloy-Hubler; Myles Brown; Mathieu Lupien; Raphaël Métivier; Gilles Salbert; Jérôme Eeckhoute
Journal:  Genome Res       Date:  2011-01-13       Impact factor: 9.043

4.  Transcriptional amplification in tumor cells with elevated c-Myc.

Authors:  Charles Y Lin; Jakob Lovén; Peter B Rahl; Ronald M Paranal; Christopher B Burge; James E Bradner; Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2012-09-28       Impact factor: 41.582

Review 5.  MYC on the path to cancer.

Authors:  Chi V Dang
Journal:  Cell       Date:  2012-03-30       Impact factor: 41.582

6.  Integration of external signaling pathways with the core transcriptional network in embryonic stem cells.

Authors:  Xi Chen; Han Xu; Ping Yuan; Fang Fang; Mikael Huss; Vinsensius B Vega; Eleanor Wong; Yuriy L Orlov; Weiwei Zhang; Jianming Jiang; Yuin-Han Loh; Hock Chuan Yeo; Zhen Xuan Yeo; Vipin Narang; Kunde Ramamoorthy Govindarajan; Bernard Leong; Atif Shahab; Yijun Ruan; Guillaume Bourque; Wing-Kin Sung; Neil D Clarke; Chia-Lin Wei; Huck-Hui Ng
Journal:  Cell       Date:  2008-06-13       Impact factor: 41.582

7.  MYC acts via the PTEN tumor suppressor to elicit autoregulation and genome-wide gene repression by activation of the Ezh2 methyltransferase.

Authors:  Mandeep Kaur; Michael D Cole
Journal:  Cancer Res       Date:  2012-11-07       Impact factor: 12.701

8.  A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells.

Authors:  Zirong Li; Sara Van Calcar; Chunxu Qu; Webster K Cavenee; Michael Q Zhang; Bing Ren
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-13       Impact factor: 11.205

9.  Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1.

Authors:  Jessica L L Robinson; Stewart Macarthur; Caryn S Ross-Innes; Wayne D Tilley; David E Neal; Ian G Mills; Jason S Carroll
Journal:  EMBO J       Date:  2011-06-24       Impact factor: 11.598

10.  An extended transcriptional network for pluripotency of embryonic stem cells.

Authors:  Jonghwan Kim; Jianlin Chu; Xiaohua Shen; Jianlong Wang; Stuart H Orkin
Journal:  Cell       Date:  2008-03-21       Impact factor: 41.582

View more
  42 in total

1.  Downregulation of Critical Oncogenes by the Selective SK2 Inhibitor ABC294640 Hinders Prostate Cancer Progression.

Authors:  Randy S Schrecengost; Staci N Keller; Matthew J Schiewer; Karen E Knudsen; Charles D Smith
Journal:  Mol Cancer Res       Date:  2015-08-13       Impact factor: 5.852

Review 2.  Targeting the androgen receptor in breast cancer.

Authors:  KeeMing Chia; Megan O'Brien; Myles Brown; Elgene Lim
Journal:  Curr Oncol Rep       Date:  2015-02       Impact factor: 5.075

Review 3.  Maintaining and reprogramming genomic androgen receptor activity in prostate cancer.

Authors:  Ian G Mills
Journal:  Nat Rev Cancer       Date:  2014-03       Impact factor: 60.716

4.  Glutamine Transporters Are Targets of Multiple Oncogenic Signaling Pathways in Prostate Cancer.

Authors:  Mark A White; Chenchu Lin; Kimal Rajapakshe; Jianrong Dong; Yan Shi; Efrosini Tsouko; Ratna Mukhopadhyay; Diana Jasso; Wajahat Dawood; Cristian Coarfa; Daniel E Frigo
Journal:  Mol Cancer Res       Date:  2017-05-15       Impact factor: 5.852

5.  Growth-promoting and tumourigenic activity of c-Myc is suppressed by Hhex.

Authors:  V Marfil; M Blazquez; F Serrano; J V Castell; R Bort
Journal:  Oncogene       Date:  2014-09-15       Impact factor: 9.867

6.  A change-point model for identifying 3'UTR switching by next-generation RNA sequencing.

Authors:  Wei Wang; Zhi Wei; Hongzhe Li
Journal:  Bioinformatics       Date:  2014-04-11       Impact factor: 6.937

7.  Anti-androgen therapy in triple-negative breast cancer.

Authors:  Valerie N Barton; Michael A Gordon; Jennifer K Richer; Anthony Elias
Journal:  Ther Adv Med Oncol       Date:  2016-05-31       Impact factor: 8.168

8.  Androgen and AR contribute to breast cancer development and metastasis: an insight of mechanisms.

Authors:  J Feng; L Li; N Zhang; J Liu; L Zhang; H Gao; G Wang; Y Li; Y Zhang; X Li; D Liu; J Lu; B Huang
Journal:  Oncogene       Date:  2016-11-28       Impact factor: 9.867

9.  Coregulator control of androgen receptor action by a novel nuclear receptor-binding motif.

Authors:  Katja Jehle; Laura Cato; Antje Neeb; Claudia Muhle-Goll; Nicole Jung; Emmanuel W Smith; Victor Buzon; Laia R Carbó; Eva Estébanez-Perpiñá; Katja Schmitz; Ljiljana Fruk; Burkhard Luy; Yu Chen; Marc B Cox; Stefan Bräse; Myles Brown; Andrew C B Cato
Journal:  J Biol Chem       Date:  2014-02-12       Impact factor: 5.157

10.  USP22 regulates oncogenic signaling pathways to drive lethal cancer progression.

Authors:  Randy S Schrecengost; Jeffry L Dean; Jonathan F Goodwin; Matthew J Schiewer; Mark W Urban; Timothy J Stanek; Robyn T Sussman; Jessica L Hicks; Ruth C Birbe; Rossitza A Draganova-Tacheva; Tapio Visakorpi; Angelo M DeMarzo; Steven B McMahon; Karen E Knudsen
Journal:  Cancer Res       Date:  2013-11-06       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.